News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
Orion and Abilita Therapeutics announce research collaboration and option to license agreement to develop innovative antibody therapeutics
Thursday, December 19, 2024Orion Corporation and Abilita Therapeutics announced today that they have entered into a research collaboration and option to license agreement to develop innovative antibody therapeutics in the areas of oncology and pain Under the terms of the agree...
Medera’s Novoheart and Curi Bio Partner to Transform Human-Based Cardiac Drug Screening
Thursday, December 19, 2024Medera Inc a clinicalstage biopharmaceutical company focused on targeting difficulttotreat or currently incurable diseases with significant unmet needs today announced that its wholly owned preclinical subsidiary for disease modelling and drug discov...
Tiziana Life Sciences Announces First Patient with Moderate Alzheimer’s Disease Dosed with Intranasal Foralumab
Wednesday, December 18, 2024Tiziana Life Sciences Ltd a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate intranasal foralumab a fully human antiCD monoclonal antibody today announced a significant milestone in its clin...
Portage Biotech Announces Letter of Intent with Immunova for an Option to Acquire iOx Therapeutics, Ltd
Wednesday, December 18, 2024Portage Biotech Inc a clinicalstage immunooncology company with a portfolio of novel multitargeted therapies for use as monotherapy and in combination is pleased to announce that it has entered into a Letter of Intent LOI with Immunova LLC Immunova a...
Brains Bioceutical Expands Industry-Leading Cannabinoid Offering with D9-THC and CBN, Unveiling New Frontiers for Drug Development
Tuesday, December 17, 2024Brains Bioceutical Corp a global leader in natural GMPcompliant cannabinoid Active Pharmaceutical Ingredients APIs announces the expansion of its industryleading offering Cannabinol CBN is available as an EUGMP certified API DTetrahydrocanabinol THC...
Biocytogen Announces Adcendo ApS Exercises Antibody Option to Accelerate ADC Development
Tuesday, December 17, 2024Biocytogen Pharmaceuticals Beijing Co Ltd a global biotech company focusing on the discovery of novel antibodyADC therapeutics announced that Adcendo ApS Adcendo a biotech company focused on the development of firstinclass antibodydrug conjugates
Lilly's Omvoh® (mirikizumab) recommended by CHMP for approval in the European Union for adults with moderately to severely active Crohn's disease
Monday, December 16, 2024Eli Lilly and Company announced today that the European Medicines Agencys EMA Committee for Medicinal Products for Human Use CHMP has issued a positive opinion for Omvoh mirikizumab an interleukinp ILp antagonist for the treatment of adults with mode...
Bavarian Nordic Enters License and Manufacturing Agreement for its Mpox Vaccine with Serum Institute of India
Monday, December 16, 2024Bavarian Nordic AS announced today a license and manufacturing agreement for its MVABN mpox vaccine with Serum Institute of India Pvt Ltd SII Under the agreement the companies will undertake a technology transfer of the current manufacturing process...
OSE Immunotherapeutics Announces Positive Clinical Progress for Late-Stage Proprietary Cancer Vaccine Tedopi®
Thursday, December 12, 2024OSE Immunotherapeutics SA provided a clinical update on Tedopi OSE the offtheshelf neoepitopebased therapeutic cancer vaccine under evaluation in a range of cancer indications where there is large unmet medical need
PolyPid Announces Research and Development Collaboration with ImmunoGenesis Leveraging PLEX Technology to Enhance Cancer Immunotherapy
Thursday, December 12, 2024PolyPid Ltd a latestage biopharma company aiming to improve surgical outcomes today announced a new research and development collaboration with ImmunoGenesis Inc ImmunoGenesis a Houstonbased clinicalstage biotechnology company developing
